middle.news
Firebrick Pharma Secures $1.4M to Boost Nasodine Growth in US and Asia
11:05pm on Friday 29th of August, 2025 AEST
•
Healthcare
Read Story
Firebrick Pharma Secures $1.4M to Boost Nasodine Growth in US and Asia
11:05pm on Friday 29th of August, 2025 AEST
Key Points
Raised $1.4 million via placement of 22.2 million shares at 6.3 cents each
Placement closes shortfall from earlier $1.6 million fundraising attempt
Funds to support Nasodine sales growth in US, Singapore, and Southeast Asia
Includes free attaching options exercisable at 9.5 cents until July 2028
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Firebrick Pharma (ASX:FRE)
OPEN ARTICLE